Kintara Therapeutics (KTRA) executive Praill bought 28,700 shares for $19.4K at $0.68
Insider transactions reported
Anthony Scott Praill (executive at Kintara Therapeutics Inc., KTRA) reported that they bought 28,700 shares for $19.4K at $0.68 on Dec 8, 2021. After these transactions the filing shows 37,186 shares held directly.
- Reporting person
- Praill Anthony Scott
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 8, 2021 | Open-market purchase (P) | Common Stock | +28,700 | $0.68 | $19.4K | 37,186 direct |
Holdings before and after
- Common Stock: 8,486 to 37,186 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Praill report in this KTRA Form 4?
Anthony Scott Praill (executive at Kintara Therapeutics Inc., KTRA) reported that they bought 28,700 shares for $19.4K at $0.68 on Dec 8, 2021. After these transactions the filing shows 37,186 shares held directly.
How many KTRA shares does Praill hold after this filing?
The filing shows 37,186 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for KTRA
Earlier insider filings at KTRA
- Dec 8, 2021SEC Form 4: Zarrabian Saiid bought $31,316 worth of shares (50,000 units at $0.63), increasing direct ownership by 909% to 55,500 units
- Nov 24, 2021SEC Form 4: Johnson Laura L. bought $2,227 worth of shares (3,000 units at $0.74)
- Nov 10, 2021SEC Form 4 filed by Hoffman Robert
- Sep 23, 2021SEC Form 4 filed by Murphy Keith
- Sep 23, 2021SEC Form 4 filed by Toth Robert Joseph Jr
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow KTRA and get a push notification the moment its next story breaks.